The spirometer market in Asia Pacific is expected to grow from US$ 210.00 million in 2022 to US$ 414.09 million by 2028. It is estimated to grow at a CAGR of 12.0% from 2022 to 2028.
Millions of people across the region are suffering from COPD and asthma, which are the two most common respiratory diseases that can seriously impact people’s health and even cause death. Patients with asthma and COPD should perform daily measurements of static and dynamic respiratory functions to track their pulmonary health and prevent exacerbations easily. Spirometers are the most common machines for such tests. They measure the volume and speed of air inhaled and exhaled to assess lung function and provide a first-level diagnostic test for pulmonary diseases and their progression. In addition, in 2018, the Indian Chest Society and the National College of Chest Physicians of India collaborated to develop evidence-based guidelines to help physicians at all healthcare levels in performing and scientifically interpreting spirometry. They jointly supported an expert group to provide recommendations for spirometry in India. Continuous initiatives by governments are likely to modernize and offer opportunities for the growth of the spirometer market during the forecast period.
Asia Pacific Spirometer Market Segmentation
The Asia Pacific spirometer market is segmented by type, technology, application, and country. Based on type, the market is segmented into handheld spirometers, table-top spirometers, and desktop spirometers. The table-top spirometers segment dominated the market in 2022. By technology, the market is segmented into volume, flow, and peak flow. The flow segment dominated the market in 2022. By application, the market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and others. The chronic obstructive pulmonary disease segment dominated the market in 2022. Based on country, the market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia Pacific. Further, China dominated the market in 2022.
A few key players dominating the Asia Pacific spirometer market are Baxter International Inc.; COSMED Srl; Henry Schein, Inc.; ICU Medical Inc.; Teleflex Incorporated; and VYAIRE MEDICAL, INC.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 210.00 Million |
| Market Size by 2028 | US$ 414.09 Million |
| CAGR (2022 - 2028) | 12.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
The Asia Pacific Spirometer Market is valued at US$ 210.00 Million in 2022, it is projected to reach US$ 414.09 Million by 2028.
As per our report Asia Pacific Spirometer Market, the market size is valued at US$ 210.00 Million in 2022, projecting it to reach US$ 414.09 Million by 2028. This translates to a CAGR of approximately 12.0% during the forecast period.
The Asia Pacific Spirometer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Spirometer Market report:
The Asia Pacific Spirometer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Spirometer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Spirometer Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Spirometer Market
